ADDvise Group AB (publ) (ADDV-A.ST)
SEK 11.2
(1.36%)
SEK 11.2
(1.36%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 1.37 Billion SEK | 44.3% |
| 2022 | 951.52 Million SEK | 104.21% |
| 2021 | 465.95 Million SEK | 29.98% |
| 2020 | 358.48 Million SEK | 2.46% |
| 2019 | 349.87 Million SEK | 30.44% |
| 2018 | 268.21 Million SEK | 11.8% |
| 2017 | 239.91 Million SEK | 22.85% |
| 2016 | 195.28 Million SEK | 33.23% |
| 2015 | 146.57 Million SEK | 6.16% |
| 2014 | 138.06 Million SEK | 15.03% |
| 2013 | 120.03 Million SEK | 19.59% |
| 2012 | 100.36 Million SEK | 98.88% |
| 2011 | 50.46 Million SEK | 126.42% |
| 2010 | 22.28 Million SEK | 0.0% |
| 2009 | - SEK | -100.0% |
| 2008 | 34.34 Million SEK | 2.98% |
| 2007 | 33.35 Million SEK | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 413.4 Million SEK | 4.13% |
| 2024 Q2 | 412.3 Million SEK | -0.27% |
| 2024 Q3 | 403.6 Million SEK | -2.11% |
| 2023 Q2 | 344.4 Million SEK | 10.92% |
| 2023 Q3 | 321.1 Million SEK | -6.77% |
| 2023 FY | 1.37 Billion SEK | 44.3% |
| 2023 Q4 | 397 Million SEK | 23.64% |
| 2023 Q1 | 310.5 Million SEK | -3.05% |
| 2022 FY | 951.52 Million SEK | 104.21% |
| 2022 Q1 | 162.39 Million SEK | 4.76% |
| 2022 Q2 | 231.9 Million SEK | 42.8% |
| 2022 Q3 | 236.96 Million SEK | 2.18% |
| 2022 Q4 | 320.26 Million SEK | 35.15% |
| 2021 FY | 465.95 Million SEK | 29.98% |
| 2021 Q1 | 87.73 Million SEK | -9.37% |
| 2021 Q2 | 117.64 Million SEK | 34.09% |
| 2021 Q3 | 105.55 Million SEK | -10.27% |
| 2021 Q4 | 155.01 Million SEK | 46.85% |
| 2020 FY | 358.48 Million SEK | 2.46% |
| 2020 Q2 | 101.8 Million SEK | 21.62% |
| 2020 Q1 | 83.7 Million SEK | -17.67% |
| 2020 Q4 | 96.81 Million SEK | 27.1% |
| 2020 Q3 | 76.16 Million SEK | -25.18% |
| 2019 Q3 | 79.13 Million SEK | -14.46% |
| 2019 FY | 349.87 Million SEK | 30.44% |
| 2019 Q1 | 76.55 Million SEK | 4.41% |
| 2019 Q2 | 92.51 Million SEK | 20.85% |
| 2019 Q4 | 101.67 Million SEK | 28.47% |
| 2018 Q2 | 67.59 Million SEK | 0.29% |
| 2018 Q4 | 73.32 Million SEK | 22.38% |
| 2018 FY | 268.21 Million SEK | 11.8% |
| 2018 Q1 | 67.39 Million SEK | 8.12% |
| 2018 Q3 | 59.91 Million SEK | -11.36% |
| 2017 Q2 | 68.27 Million SEK | 10.26% |
| 2017 FY | 239.91 Million SEK | 22.85% |
| 2017 Q4 | 62.33 Million SEK | 31.53% |
| 2017 Q3 | 47.39 Million SEK | -30.59% |
| 2017 Q1 | 61.92 Million SEK | 16.38% |
| 2016 FY | 195.28 Million SEK | 33.23% |
| 2016 Q3 | 42.24 Million SEK | -21.97% |
| 2016 Q4 | 53.2 Million SEK | 25.93% |
| 2016 Q2 | 54.14 Million SEK | 18.51% |
| 2016 Q1 | 45.68 Million SEK | 25.28% |
| 2015 FY | 146.57 Million SEK | 6.16% |
| 2015 Q1 | 41.01 Million SEK | -1.64% |
| 2015 Q2 | 37.35 Million SEK | -8.91% |
| 2015 Q3 | 31.74 Million SEK | -15.04% |
| 2015 Q4 | 36.46 Million SEK | 14.9% |
| 2014 Q4 | 41.69 Million SEK | 54.89% |
| 2014 Q1 | 34.19 Million SEK | -7.87% |
| 2014 Q2 | 35.25 Million SEK | 3.09% |
| 2014 Q3 | 26.91 Million SEK | -23.65% |
| 2014 FY | 138.06 Million SEK | 15.03% |
| 2013 Q4 | 37.12 Million SEK | 51.96% |
| 2013 FY | 120.03 Million SEK | 19.59% |
| 2013 Q1 | 26.43 Million SEK | -24.4% |
| 2013 Q2 | 32.05 Million SEK | 21.26% |
| 2013 Q3 | 24.42 Million SEK | -23.79% |
| 2012 Q3 | 21.97 Million SEK | 1.24% |
| 2012 Q1 | 21.83 Million SEK | 27.8% |
| 2012 Q2 | 21.71 Million SEK | -0.58% |
| 2012 Q4 | 34.96 Million SEK | 59.07% |
| 2012 FY | 100.36 Million SEK | 98.88% |
| 2011 FY | 50.46 Million SEK | 126.42% |
| 2011 Q3 | 9.98 Million SEK | -16.46% |
| 2011 Q4 | 17.08 Million SEK | 71.19% |
| 2011 Q1 | 11.74 Million SEK | 2.73% |
| 2011 Q2 | 11.94 Million SEK | 1.74% |
| 2010 FY | 22.28 Million SEK | 0.0% |
| 2010 Q4 | 11.43 Million SEK | 350.26% |
| 2010 Q3 | 2.53 Million SEK | -41.54% |
| 2010 Q2 | 4.34 Million SEK | 9.26% |
| 2010 Q1 | 3.97 Million SEK | 0.0% |
| 2009 Q4 | - SEK | 0.0% |
| 2009 FY | - SEK | -100.0% |
| 2009 Q2 | 9.9 Million SEK | -3.97% |
| 2009 Q1 | 10.31 Million SEK | 9.8% |
| 2009 Q3 | - SEK | -100.0% |
| 2008 FY | 34.34 Million SEK | 2.98% |
| 2008 Q1 | 10.27 Million SEK | 15.88% |
| 2008 Q2 | 8.83 Million SEK | -14.02% |
| 2008 Q4 | 9.39 Million SEK | 0.0% |
| 2007 Q4 | 8.86 Million SEK | 0.0% |
| 2007 FY | 33.35 Million SEK | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Acarix AB (publ) | 6.24 Million SEK | -21899.68% |
| ADDvise Group AB (publ) | 1.37 Billion SEK | 0.0% |
| Arcoma AB | 163.01 Million SEK | -742.254% |
| Bactiguard Holding AB (publ) | 203.99 Million SEK | -573.072% |
| BICO Group AB (publ) | 2.23 Billion SEK | 38.692% |
| Boule Diagnostics AB (publ) | 571.32 Million SEK | -140.317% |
| CellaVision AB (publ) | 677.29 Million SEK | -102.719% |
| Clinical Laserthermia Systems AB (publ) | 8.27 Million SEK | -16496.156% |
| Chordate Medical Holding AB (publ) | 976.28 Thousand SEK | -140535.739% |
| C-Rad AB (publ) | 424.61 Million SEK | -223.352% |
| Duearity AB (publ) | 1.65 Million SEK | -82910.883% |
| Dignitana AB (publ) | 86.06 Million SEK | -1495.343% |
| Episurf Medical AB (publ) | 10.3 Million SEK | -13230.097% |
| Getinge AB (publ) | 31.82 Billion SEK | 95.686% |
| Scandinavian Real Heart AB (Publ) | - SEK | -Infinity% |
| Iconovo AB (publ) | 7.07 Million SEK | -19297.346% |
| Integrum AB (publ) | 104.11 Million SEK | -1218.688% |
| Luxbright AB (publ) | 854.69 Thousand SEK | -160541.349% |
| Mentice AB (publ) | 273.61 Million SEK | -401.809% |
| OssDsign AB (publ) | 112.15 Million SEK | -1124.177% |
| Paxman AB (publ) | 210.11 Million SEK | -553.445% |
| Promimic AB (publ) | 37.07 Million SEK | -3603.804% |
| Qlife Holding AB (publ) | 244 Thousand SEK | -562604.918% |
| SciBase Holding AB (publ) | 23.24 Million SEK | -5806.647% |
| ScandiDos AB (publ) | 60.42 Million SEK | -2172.088% |
| Sectra AB (publ) | 2.96 Billion SEK | 53.671% |
| Sedana Medical AB (publ) | 153.86 Million SEK | -792.329% |
| Senzime AB (publ) | 35.75 Million SEK | -3740.13% |
| SpectraCure AB (publ) | 318 Thousand SEK | -431661.006% |
| Stille AB | 294.89 Million SEK | -365.593% |
| Vitrolife AB (publ) | 3.51 Billion SEK | 60.905% |
| Xvivo Perfusion AB (publ) | 597.54 Million SEK | -129.775% |